CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer

Annals of Otology, Rhinology and Laryngology

Volumn 109, Issue 8 I, 2000, Pages 749-754

  Pandit, R ^a   Lathers, D M R ^a   Garrity, T ^a   Beal, N M ^a   Young, M R I ^a  

^a HINES VA HOSPITAL   (United States)

Author keywords

Cancer; CD34+; Cells; Head and neck squamous cell carcinoma; Immune suppression; Immune suppressor cells

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 2;

ARTICLE; CONTROLLED STUDY; HEAD CANCER; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; NECK CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

EID: 0033870235     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940010900809     Document Type: Article

References (30)

1. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells
2. Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer
3. Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer
4. Interleukins and contrasuppression induce immune regression of head and neck cancer
5. Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells
6. Update on immunology of head and neck cancer
7. Immunobiologic aspects of head and neck cancer
8. In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like transmembrane factors in operable head and neck squamous cell carcinoma patients
9. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2
10. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage
11. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses
12. Production of a suppressor of lymphocyte proliferation by two human oral carcinoma cell lines
13. Mechanisms of tumor-induced immunosuppression: Evidence for contact-dependent T cell suppression by monocytes
14. Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2
15. Phenotypic analysis of nylon-wooladherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma
16. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-γ
17. Analysis of immunosuppressive mechanism to cytotoxic T lymphocyte generation in patients with advanced cancer
18. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients: The role of the adherent mononuclear cell
19. Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer
20. An immunological out-come predictive score for head and neck carcinoma patients
21. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: Interferon-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of bone marrow cells, and diminish tumor recurrence and metastasis
22. Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF
23. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide
24. + cells in cancers that secrete granulocyte-macrophage colony-stimulating factor
25. + natural suppressor cells
26. Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
27. Tumour dormancy: Initiation, maintenance and termination in animals and humans
28. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer
29. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production. Role of tumor-derived IL-10, TGF-B, and prostaglandin E2
30. T-cell subset analysis of Lewis lung carcinoma tumor rejection: Heterogeneity of effectors and evidence for negative regulatory lymphocytes correlating with metastasis